* RESORB Study Marks Major Step Toward U.S. Regulatory Approval and Global Commercialization SEOU...
* Safety and Excellent Pain Relief Effect after Musculoskeletal Pain Embolization SEOUL, South Ko...
Pioneering a Paradigm Shift in Pain Treatment, Accelerating Global Market Expansion SEOUL, South K...
SEOUL, South Korea, Jan. 15, 2025 /PRNewswire/ -- NEXTBIOMEDICAL CO., LTD, a KOSDAQ-listed innovati...